menu
    • menu

    Company profile for Vir Biotechnology

    NEW Drugs in Dev: 13
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vir is a science-driven company guided by medical need. Vir integrates diverse innovations in science, technology, and medicine to transform the care of people with serious infectious diseases. Vir is taking a multi-program, multi-platform approach to applying these breakthroughs, including the development of treatments that induce protective and therapeutic immune responses. Vir’s scale and scope, together with leading scie...
    Vir is a science-driven company guided by medical need. Vir integrates diverse innovations in science, technology, and medicine to transform the care of people with serious infectious diseases. Vir is taking a multi-program, multi-platform approach to applying these breakthroughs, including the development of treatments that induce protective and therapeutic immune responses. Vir’s scale and scope, together with leading scientific and management expertise, allow it to perform significant internal R&D, in-license or acquire innovative technology platforms and assets, and fund targeted academic research

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vir BiotechnologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    499 Illinois Suite 500 San Francisco, CA 94158
    Telephone
    Telephone
    415-906-4324
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vir.bio/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASCO GU

    ASCO GU

    Not Confirmed

    envelop Contact Supplier

    ASCO GU

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Astellas says ‘I do’ to Vir’s T-cell engager in $1.7 billion deal
    Astellas says ‘I do’ to Vir’s T-cell engager in $1.7 billion deal

    24 Feb 2026

    // FIERCE PHARMA

    https://www.fiercebiotech.com/biotech/astellas-vir-engage-17b-deal-masked-prostate-cancer-bispecific

    FIERCE PHARMA
    24 Feb 2026
    Share Share
    Vir Bio Updates On Corporate Progress And 2025 Financials
    Vir Bio Updates On Corporate Progress And 2025 Financials

    23 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260222469334/en/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    23 Feb 2026
    Share Share
    Vir Bio To Host Call On Q4 & Full Year 2025 Financial Results
    Vir Bio To Host Call On Q4 & Full Year 2025 Financial Results

    09 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260209367749/en/Vir-Biotechnology-to-Host-Conference-Call-for-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    09 Feb 2026
    Share Share
    Vir Bio Updates Hepatitis Delta and Oncology Programs
    Vir Bio Updates Hepatitis Delta and Oncology Programs

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/vir-biotechnology-provides-updates-on-chronic-hepatitis-delta-and-oncology-programs-and-upcoming-202

    PHARMIWEB
    12 Jan 2026
    Share Share
    Vir Biotech To Present At 44th J.P. Morgan Healthcare Conference
    Vir Biotech To Present At 44th J.P. Morgan Healthcare Conference

    06 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-06/vir-biotechnology-to-present-at-the-44th-annual-jp-morgan-healthcare-conference

    PHARMIWEB
    06 Jan 2026
    Share Share
    Vir Bio To Present At 44Th J.P. Morgan Healthcare Conference
    Vir Bio To Present At 44Th J.P. Morgan Healthcare Conference

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105543597/en/Vir-Biotechnology-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    05 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search